Livedo reticularis
Livedo reticularis ni ugunduzi wa kawaida wa ngozi unaojumuisha muundo wa mishipa iliyo na madoadoa, unaoonekana kama rangi ya zambarau inayofanana na ngozi. Inaweza kuchochewa na baridi, na hutokea mara nyingi katika miguu ya chini. Kubadilika kwa rangi husababishwa na kupungua kwa mtiririko wa damu kupitia mishipa ya kapilari ya ngozi, na kusababisha damu isiyo na oksijeni kuonekana kama mabadiliko ya rangi ya bluu. Hii inaweza kusababishwa na hali ya pili ya hyperlipidemia, ugonjwa wa mishipa madogo, upungufu wa damu, lishe duni, magonjwa ya hyper- na autoimmune, pamoja na dawa au sumu.
☆ AI Dermatology — Free Service
Katika matokeo ya 2022 ya Stiftung Warentest kutoka Ujerumani, kuridhika kwa watumiaji na ModelDerm kulikuwa chini kidogo kuliko na mashauriano ya matibabu ya simu yanayolipishwa.
Katika matokeo ya 2022 ya Stiftung Warentest kutoka Ujerumani, kuridhika kwa watumiaji na ModelDerm kulikuwa chini kidogo kuliko na mashauriano ya matibabu ya simu yanayolipishwa.
Kidonda kutokana na stenosis kali ya aortoiliac ya infrarenal.
relevance score : -100.0%
ReferencesLivedo reticularis (LR) ni hali ya ngozi yenye alama za muda au za kudumu, inayoonyesha madoadoa ya rangi nyekundu‑buluu hadi zambarau, na muundo unaofanana na wavu. Mara nyingi huathiri wanawake wa makamo na kwa kawaida haina dalili. Kwa upande mwingine, livedo racemosa (LRC) ni aina mbaya zaidi ambayo mara nyingi huhusishwa na ugonjwa wa antiphospholipid.
Livedo reticularis (LR) is a cutaneous physical sign characterized by transient or persistent, blotchy, reddish-blue to purple, net-like cyanotic pattern. LR is a benign disorder affecting mainly middle-aged females, whereas livedo racemosa (LRC) is pathologic, commonly associated with antiphospholipid antibody syndrome.
Livedo reticularis (LR) is a cutaneous physical sign characterized by transient or persistent, blotchy, reddish-blue to purple, net-like cyanotic pattern. LR is a benign disorder affecting mainly middle-aged females, whereas livedo racemosa (LRC) is pathologic, commonly associated with antiphospholipid antibody syndrome.
